Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2025-12-15 Transaction in Own Shar…
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the sale of treasury shares by 'Sopharma' AD. It explicitly details the number of shares sold, the transaction date, the total value, and the resulting change in the company's treasury share holdings. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2025-12-15 English
Corrective notification of an initial notification published on 11.12.2025 from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions by persons discharging managerial responsibilities (PDMRs) under the EU Market Abuse Regulation (MAR). It explicitly identifies the individual (Ognian Ivanov Donev), his position (Executive Director and Chairman), the issuer (Sopharma AD), and details of the financial instrument (shares). This is a classic 'Director's Dealing' or 'Insider Trading' disclosure.
2025-12-12 English
Corrective notification of an initial notification published on 11.12.2025 from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD
Director's Dealing Classification · 100% confidence The document follows the standard template for 'Notification of transactions by persons discharging managerial responsibilities' as required by Article 19 of the EU Market Abuse Regulation (MAR). It explicitly identifies the person discharging managerial responsibilities (Ognian Ivanov Donev), their position (Executive Director/Chairman), the issuer (Sopharma AD), and details of the share transaction (buy, price, volume). This is a classic Director's Dealing report.
2025-12-12 English
Corrective notification of an initial notification published on 04.12.2025 from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions conducted by persons discharging managerial responsibilities (PDMRs), specifically Ognian Ivanov Donev, an Executive Director of Sopharma AD. It explicitly references Regulation (EU) No 596/2014 (Market Abuse Regulation) and provides details on the nature of the transaction (buy), the financial instrument (shares), and the price/volume. This is a classic 'Director's Dealing' or 'Insider Trading' disclosure.
2025-12-12 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a formal notification regarding the sale of treasury shares by 'Sopharma' AD. It specifies the number of shares sold, the transaction date, the price, and the resulting change in the company's treasury share holdings. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2025-12-12 English
Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD
Director's Dealing Classification · 100% confidence The document is a standard template for reporting transactions by persons discharging managerial responsibilities (PDMRs) under the EU Market Abuse Regulation (MAR). It explicitly identifies the individual (Ognian Ivanov Donev), their position (Executive Director/Chairman), the issuer (Sopharma AD), and details of the share purchase transaction (price, volume, and nature of the transaction). This is a classic 'Director's Dealing' notification.
2025-12-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.